CRISPR and the Gene Revolution
Understanding the Complex: What is CRISPR really — and why is it simultaneously the most promising medical technology in decades and the most serious biosecurity risk of our time? 11 lessons, ~150 minutes, free.
CRISPR and the Gene Revolution
All 11 lessons in order.
What's This Actually About?
Hook: the first Casgevy patient in 2023 — and He Jiankui's CRISPR babies in 2018. What these two events together reveal about the technology.
Why Should I Care?
Three reasons CRISPR matters beyond medicine: healing, biosecurity, and the ethics of human nature.
The Basics You Need
Prerequisites: DNA as code, somatic vs. germline. Anchor: sickle cell disease introduced.
How CRISPR-Cas9 Actually Works
Bacterial immune system → molecular scissors + GPS. sgRNA, Cas9, repair mechanisms. How it corrects sickle cell.
Three Application Domains: Therapy, Germline, Gene Drives
Somatic gene therapy (Casgevy), germline editing (He Jiankui), gene drives. What each domain can do — and what each warns against.
Where Do We Actually Stand? Casgevy, Cancer, Limits
Casgevy fully explained ($2.2M price tag). Cancer immunotherapy trials. The fundamental limits. Anchor resolved.
Who's Doing This? Why? Who's Paying?
Doudna, Charpentier (Max Planck Berlin), Zhang, He Jiankui, Esvelt, Baltimore, Church. NIH, Gates, publicly-traded companies. As of May 2026.
What's Contested? What Don't We Know?
Four controversies: germline editing — when? Gene drives — justifiable? Who regulates? Designer babies.
What's Next?
Five milestones on the path to broader CRISPR application.
What If...?
Calibrated speculation ~50/50 — with strict operational uplift limits throughout.
What Do You Take Away?
Six core ideas. Reading list. Cross-links to Nuclear Fusion and Climate Models. Why you shouldn't trust us blindly.